Slideshow

7 New Drugs for Neurologists

Author(s):

Julie Bowen

Here’s a brief look at therapies for neurological disorders that the FDA has approved within the past 6 months.

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Subscribe Now!
Related Videos
Sumaira Ahmed
Related Content
Phase 2 Study to Test Therapeutic Potential of Samelisant for Narcolepsy Type 1
June 12th 2025

Phase 2 Study to Test Therapeutic Potential of Samelisant for Narcolepsy Type 1

Marco Meglio
Episode 142: World MS Day: Raising Awareness, Evolving Care, and Empowering Patients
May 30th 2025

Episode 142: World MS Day: Raising Awareness, Evolving Care, and Empowering Patients

Marco Meglio Taylor Hess, MD
Small-Scale Study Highlights Positive Impacts of Once-Nightly Sodium Oxybate on Sleep-Related Eating Disorder
June 11th 2025

Small-Scale Study Highlights Positive Impacts of Once-Nightly Sodium Oxybate on Sleep-Related Eating Disorder

Marco Meglio
Episode 141: Refining TSC Care: Phenotyping, Clustering, and Clinical Impact
May 16th 2025

Episode 141: Refining TSC Care: Phenotyping, Clustering, and Clinical Impact

Marco Meglio Ajay Gupta, MD
Logan Schneider, MD (Credit: Stanford University)
June 11th 2025

Low-Sodium Oxybate Improves Daytime Sleepiness and Sleep Architecture in Phase 4 Narcolepsy Trial

Isabella Ciccone, MPH
NeuroVoices: Andrew Varga, MD, on Debating Whether Brain Cleansing Prevents Alzheimer Disease
June 11th 2025

NeuroVoices: Andrew Varga, MD, on Debating Whether Brain Cleansing Prevents Alzheimer Disease

Marco Meglio
© 2025 MJH Life Sciences

All rights reserved.